| 1 |
35408447 | Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases. | 2022 Mar 22 |
2 |
| 2 |
35549373 | Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease. | 2022 May 13 |
1 |
| 3 |
34530706 | Interactions between ACE2 and SARS-CoV-2 S Protein: Peptide Inhibitors for Potential Drug Developments Against COVID-19. | 2021 |
1 |
| 4 |
34806090 | Hypertension and its management in COVID-19 patients: The assorted view. | 2021 Dec |
2 |
| 5 |
32507883 | Covid-19: the renin-angiotensin system imbalance hypothesis. | 2020 Jun 12 |
1 |
| 6 |
32582222 | The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe? | 2020 |
2 |
| 7 |
32966970 | Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2. | 2020 Nov |
1 |
| 8 |
31141400 | Role of ADAM17 in kidney disease. | 2019 Aug 1 |
4 |
| 9 |
32362932 | Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure. | 2012 Winter |
3 |